X4 Pharmaceuticals Inc (XFOR)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

5,817,726 $5,061,422 0.09%
2.
Perceptive Advisors

Joseph Edelman

4,545,454 $3,954,545 0.11%
3.
Tri Locum Partners

Prashanth Jayaram

3,878,484 $3,374,281 +5% 1.02%
4. 2,797,147 $2,433,518 +18% 0.52%
5. 1,037,000 $902,190 +16% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$10.00 20,000 Large Shareholder 370,454 2017-11-20 Filing
$10.00 300,000 Large Shareholder 867,639 2017-11-20 Filing
$10.00 300,000 Director 867,639 2017-11-20 Filing
$10.00 16,552 Large Shareholder 1,868,961 2017-11-20 Filing
$10.00 483,448 Large Shareholder 1,852,409 2017-11-20 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.95 6,292 Officer, Director 557,245 2023-05-31 Filing
$0.84 18,192 Officer 152,714 2023-03-10 Filing
$0.84 52,500 Officer 93,696 2023-03-10 Filing
$0.84 16,806 Officer 86,373 2023-03-10 Filing
$0.84 49,678 Officer, Director 563,537 2023-03-10 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 11,736,793 $10,211,010 0.7%
2. 4,396,468 $3,824,927 0.01%
3. 4,344,311 $3,779,551 0%
4. 1,108,684 $964,555 0%
5. 900,000 $783,000 0.7%
News See All